[6-min read] Q&A with Jesse Gould, Veteran & Founder
[4-min read] MindMed patents antidepressant-psychedelic combination treatment.
[6-min read] Q&A with Talia Eisenberg, Serial Entrepreneur
[4-min read] California gets its third psychedelics ballot proposal.
[6-min read] Q&A with Jeannie Fontana, Founder & CEO
[5-min read] Stanford researchers study ketamine under surgical anesthesia.
[6-min read] Q&A with Nicholas Levich, Coach & Cofounder
[5-min read] FDA issues warning on off-label ketamine use.
[5-min read] Q&A with Spencer Hawkswell, Patient Advocate & CEO
[5-min read] California governor vetoes psychedelic decrim bill.
[7-min read] Q&A with Reid Robison, Chief Clinical Officer
[5-min read] FDA accepts PharmaTher’s NDA for KETARX.